Reducing long-term health issues in childhood cancer survivors
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
This study is looking at childhood cancer survivors to understand how their genes might affect their chances of developing health issues later on, so we can find ways to help them stay healthier as they grow up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10904693 on NIH RePORTER |
What this research studies
This research focuses on childhood cancer survivors who face a high risk of chronic health conditions due to their treatment. By examining the genetic factors that contribute to this risk, the study aims to identify individuals who are more likely to develop serious health problems later in life. The approach combines insights from molecular biology and pharmacogenomics to create targeted interventions that could help mitigate these risks. Ultimately, the goal is to improve the long-term health outcomes for these survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have survived childhood cancer and are at risk for treatment-related chronic health conditions.
Not a fit: Patients who have not survived childhood cancer or those who do not have a history of treatment with radiation or anthracyclines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized prevention strategies that significantly reduce the risk of life-threatening health issues in childhood cancer survivors.
How similar studies have performed: Previous research has shown promise in identifying genetic predispositions to treatment-related complications in cancer survivors, suggesting that this approach could be effective.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bhatia, Smita — University of Alabama at Birmingham
- Study coordinator: Bhatia, Smita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.